Additionally, MPT0B098, a microtubule inhibitor, significantly reduces HuR translocation from the nucleus to the cytoplasm in various tumor cells, leading to decreased hypoxia-inducible factor 1-α (HIF-1-α) protein expression [38]. Here, ELAVL1 is linked to neoplasm.